WaveMan · Form 4
Gault Cheryl insider trades
> Search tickers & screens ⌘K
LIVE

Gault Cheryl insider trades

Gault Cheryl has filed 12 Form 4s with the SEC that we hold, for Rapport Therapeutics, Inc. (RAPP) (Chief Operating Officer) and Korsana Biosciences, Inc. (CYCN) (Chief Operating Officer). Across all of them we count 0 purchases worth $0 and 11 sales worth $1.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($1.2M). The largest single trade was a sale of 7,925 shares of Rapport Therapeutics, Inc. worth $261.8K, dated 2026-09-30. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-10 and the latest 2026-10-01.

Rapport Therapeutics, Inc. (RAPP)

Chief Operating Officer · 10 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-09-08S, sale reported on Form 45,000$191.7K2025-09-10
2025-11-26S, sale reported on Form 45,000$150.5K2025-12-01
2026-03-05S, sale reported on Form 42,014$58.3K2026-03-09
2026-03-30S, sale reported on Form 47,161$200.8K2026-03-31
2026-03-30S, sale reported on Form 42,839$81.1K2026-03-31
2026-06-30S, sale reported on Form 41,900$76.2K2026-07-01
2026-06-30S, sale reported on Form 43,792$157.0K2026-07-01
2026-06-30S, sale reported on Form 43,308$139.5K2026-07-01
2026-06-30S, sale reported on Form 41,000$43.2K2026-07-01
2026-09-30S, sale reported on Form 47,925$261.8K2026-10-01
2026-09-30S, sale reported on Form 42,075$70.0K2026-10-01

Korsana Biosciences, Inc. (CYCN)

Chief Operating Officer · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1839046) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms